Eva Karlsson

1.6k total citations
30 papers, 1.1k citations indexed

About

Eva Karlsson is a scholar working on Geriatrics and Gerontology, Pediatrics, Perinatology and Child Health and Oncology. According to data from OpenAlex, Eva Karlsson has authored 30 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Geriatrics and Gerontology, 8 papers in Pediatrics, Perinatology and Child Health and 6 papers in Oncology. Recurrent topics in Eva Karlsson's work include Pharmaceutical Practices and Patient Outcomes (10 papers), Pharmaceutical studies and practices (8 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). Eva Karlsson is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (10 papers), Pharmaceutical studies and practices (8 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). Eva Karlsson collaborates with scholars based in Sweden, United Kingdom and United States. Eva Karlsson's co-authors include Ulla Wilking, Jonas Bergh, Thomas Hatschek, Linda S. Lindström, Lambert Skoog, Elisabet Lidbrink, Johan Hartman, Ulla Johansson, Johanna Ulfvarson and Lars L. Gustafsson and has published in prestigious journals such as Journal of Clinical Oncology, European Journal of Cancer and Atherosclerosis.

In The Last Decade

Eva Karlsson

28 papers receiving 1.1k citations

Peers

Eva Karlsson
Michael N. Neuss United States
Virginie Nerich France
Vasily Giannakeas Canada
Gabriel A. Brooks United States
Lee N. Newcomer United States
Eliot Fishman United States
Steven T. Fleming United States
Miguel Ángel Calleja‐Hernández Spain
Kerin B. Adelson United States
Erin P. Balogh United States
Michael N. Neuss United States
Eva Karlsson
Citations per year, relative to Eva Karlsson Eva Karlsson (= 1×) peers Michael N. Neuss

Countries citing papers authored by Eva Karlsson

Since Specialization
Citations

This map shows the geographic impact of Eva Karlsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Karlsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Karlsson more than expected).

Fields of papers citing papers by Eva Karlsson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Karlsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Karlsson. The network helps show where Eva Karlsson may publish in the future.

Co-authorship network of co-authors of Eva Karlsson

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Karlsson. A scholar is included among the top collaborators of Eva Karlsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Karlsson. Eva Karlsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Kjällquist, Una, Rikard Erlandsson, Nicholas P. Tobin, et al.. (2018). Exome sequencing of primary breast cancers with paired metastatic lesions reveals metastasis-enriched mutations in the A-kinase anchoring protein family (AKAPs). BMC Cancer. 18(1). 174–174. 20 indexed citations
3.
Bastholm‐Rahmner, Pia, Lars L. Gustafsson, Jaran Eriksen, et al.. (2018). Patients’ knowledge and attitudes to the Wise List - a drug formulary from the Stockholm Drug and Therapeutic committee. BMC Health Services Research. 18(1). 176–176.
4.
Eriksen, Jaran, et al.. (2018). High adherence to the “Wise List” treatment recommendations in Stockholm: a 15-year retrospective review of a multifaceted approach promoting rational use of medicines. Proceedings for Annual Meeting of The Japanese Pharmacological Society. WCP2018(0). OR8–2. 2 indexed citations
5.
Eriksen, Jaran, Lars L. Gustafsson, Pia Bastholm‐Rahmner, et al.. (2017). High adherence to the ‘Wise List’ treatment recommendations in Stockholm: a 15-year retrospective review of a multifaceted approach promoting rational use of medicines. BMJ Open. 7(4). e014345–e014345. 70 indexed citations
6.
Eriksen, Jaran, et al.. (2017). Primary care physicians report high trust in and usefulness of the Stockholm drug and therapeutic committee’s list of recommended essential medicines (the ‘Wise List’). European Journal of Clinical Pharmacology. 74(1). 131–138. 15 indexed citations
7.
Karlsson, Eva, et al.. (2016). Medication errors as malpractice-a qualitative content analysis of 585 medication errors by nurses in Sweden. BMC Health Services Research. 16(1). 431–431. 50 indexed citations
8.
9.
Falato, Claudette, Julie Lorent, Edneia Tani, et al.. (2014). Ki67 measured in metastatic tissue and prognosis in patients with advanced breast cancer. Breast Cancer Research and Treatment. 147(2). 407–414. 22 indexed citations
10.
Lindström, Linda S., Eva Karlsson, Ulla Wilking, et al.. (2012). Clinically Used Breast Cancer Markers Such As Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 Are Unstable Throughout Tumor Progression. Journal of Clinical Oncology. 30(21). 2601–2608. 370 indexed citations
11.
Gustafsson, Lars L., Björn Wettermark, Brian Godman, et al.. (2011). The ‘Wise List’– A Comprehensive Concept to Select, Communicate and Achieve Adherence to Recommendations of Essential Drugs in Ambulatory Care in Stockholm. Basic & Clinical Pharmacology & Toxicology. 108(4). 224–233. 184 indexed citations
12.
Ulfvarson, Johanna, et al.. (2010). Medication reviews with computerised expert support. International Journal of Health Care Quality Assurance. 23(6). 571–582. 12 indexed citations
13.
Wilking, Ulla, Eva Karlsson, Lambert Skoog, et al.. (2010). HER2 status in a population-derived breast cancer cohort: discordances during tumor progression. Breast Cancer Research and Treatment. 125(2). 553–561. 94 indexed citations
14.
Karlsson, Eva, et al.. (2009). Periodontitis from the patient’s perspective, a qualitative study. International Journal of Dental Hygiene. 7(1). 23–30. 23 indexed citations
15.
Ulfvarson, Johanna, et al.. (2009). Nurse-led medication reviews and the quality of drug treatment of elderly hospitalized patients. European Journal of Clinical Pharmacology. 65(11). 1089–1096. 18 indexed citations
16.
Ulfvarson, Johanna, et al.. (2008). A nurse-led intervention for identification of drug-related problems. European Journal of Clinical Pharmacology. 64(5). 451–456. 13 indexed citations
17.
Mannheimer, Buster, et al.. (2006). Drug-related problems and pharmacotherapeutic advisory intervention at a medicine clinic. European Journal of Clinical Pharmacology. 62(12). 1075–1081. 42 indexed citations
18.
Linderholm, Barbro, Eva Karlsson, Sigrid Klaar, et al.. (2004). Thrombospondin-1 expression in relation to p53 status and VEGF expression in human breast cancers. European Journal of Cancer. 40(16). 2417–2423. 11 indexed citations
19.
Gustafsson, Lars L., et al.. (2003). [Computerized decision support in drug prescribing II: A national database to provide up-to-date and unbiased information].. PubMed. 100(15). 1338–40, 1343. 2 indexed citations
20.
Bhutta, Zulfiqar A, Peter Bang, Eva Karlsson, et al.. (1999). Insulin-like growth factor I response during nutritional rehabilitation of persistent diarrhoea. Archives of Disease in Childhood. 80(5). 438–442. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael N. Neuss Breakdown of academic impact, for papers by Virginie Nerich Breakdown of academic impact, for papers by Vasily Giannakeas Breakdown of academic impact, for papers by Gabriel A. Brooks Breakdown of academic impact, for papers by Lee N. Newcomer Breakdown of academic impact, for papers by Eliot Fishman Breakdown of academic impact, for papers by Steven T. Fleming Breakdown of academic impact, for papers by Miguel Ángel Calleja‐Hernández Breakdown of academic impact, for papers by Kerin B. Adelson Breakdown of academic impact, for papers by Erin P. Balogh
Rankless by CCL
2026